|Description||PTC-209 is a potent BMI-1 inhibitor with potential anticancer activity. PTC-209 inhibits endogenous BMI-1 expression in human colorectal HCT116 and human fibrosarcoma HT1080 tumor cells.|
|B0084-462442||25 mg||$188||In stock|
|Synonyms||PTC-209; PTC 209; PTC209|
Isoalantolactone has the capacity to inhibit tumor cell growth through induction of apoptosis.
FR-168888 Free Base
The free base of FR-168888, a guanidine compound, has been found to be a sodium hydrogen antiporter inhibitor that was once studied in myocardial ischaemia ther...
ESI-09 is a specific exchange protein directly activated by cAMP (EPAC) inhibitor with IC50 of 3.2 μM and 1.4 μM for EPAC1 and EPAC2, respectively, >100-fold se...
This active molecular is an potential cognitive enhancer originated by Bristol-Myers Squibb. Mechanism of Action is not identified. Bmy 21502 is also a nootropi...
RO5263397 is a selective trace amine-associated receptor 1(TAAR1) agonist. TAAR1 is a drug discovery target for cocaine addiction. RO5263397 is efficacious in r...
CGP-62198A, a piperidine derivative, could probably be useful in some biological studies.
Ikarisoside F, a flavonol glycoside from Vancouveria hexandra, could bind to AdoHcy hydrolase.
Alismoxide is a natural product extracted from the tubers of Alisma plantago-aquatica. It has anti-inflammatory effects.